Albemarle Corporation Form 4 Filings

ALBEMARLE CORP (symbol: ALB) is the issuer of record for a Form 4 filing submitted to the SEC. Norris Eric reported acquisition or exercise transactions in this Form 4 filing.

ALBEMARLE CORP (ALB) reported that Chief Commercial Officer Eric Norris received an equity award on September 14, 2026. He was granted 10,867 shares in the form of Restricted Stock Units that vest 100% on March 14, 2028, increasing his directly held position to 64,310 shares. No Rule 10b5-1 trading plan is reported in connection with this award.

ALBEMARLE CORP (symbol: ALB) is the issuer of record for a Form 4 filing submitted to the SEC. Mummert Mark Richard reported acquisition or exercise transactions in this Form 4 filing.

ALBEMARLE CORP (ALB) reported that Chief Operations Officer Mark Richard Mummert received an equity compensation award of 6,086 shares of Common Stock on September 14, 2026. The award consists of Restricted Stock Units that vest 100% on March 14, 2028, subject to the terms of the award agreement, and increases his directly held shares to 23,601.

ALBEMARLE CORP (ALB) reported that Chief People Officer Autumn M. Gagarinas acquired 5,217 shares of common stock on September 14, 2026 through a grant of Restricted Stock Units. These RSUs vest 50% on March 14, 2028 and 50% on September 14, 2029, bringing her reported direct holdings to 10,610 shares.

ALBEMARLE CORP (symbol: ALB) is the issuer of record for a Form 4 filing submitted to the SEC. Hood Max reported acquisition or exercise transactions in this Form 4 filing.

ALBEMARLE CORP (ALB) reported that Chief Accounting Officer Max Hood received an equity compensation award on September 1, 2026. The award consists of 1,476 shares of common stock in the form of Restricted Stock Units that were granted at no cash purchase price and are held directly. These Restricted Stock Units vest in three equal installments on each of the first, second, and third anniversary of the grant date, and Hood will own the underlying shares as they vest, subject to the terms of the award agreement.

DESALLES BARTOLOMEO EDUARDO reported acquisition or exercise transactions in this Form 4 filing.

Albemarle Corporation director Desalles Bartolomeo Eduardo received a grant of 1,375 shares of common stock as non-employee director compensation. The pro rata award, made under the Albemarle Corporation 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors, was granted on July 21, 2026 and is scheduled to vest on July 1, 2027. Following this award, he directly holds 1,375 common shares.

ALBEMARLE CORP director Glenda J. Minor received a grant of 1,250 Phantom Stock units tied to common shares. The award represents non-employee director stock compensation under the 2023 Directors Plan and converts into common stock on a 1-for-1 basis.

The units are scheduled to vest on July 1, 2027 and are payable as shares of common stock upon events she establishes under the plan’s terms. Following this grant, Minor holds a total of 5,606 Phantom Stock units, which also accrue dividend equivalent rights and have no expiration date.

Collins Michelle T reported acquisition or exercise transactions in this Form 4 filing.

ALBEMARLE CORP director Michelle T. Collins reported stock-based compensation grants, not open-market trades. On July 1, 2026 she received 1,250 shares of common stock as an annual non-employee director award under the 2023 Directors Plan, scheduled to vest on July 1, 2027. She also received 2 additional shares representing dividends accrued on a prior award granted on February 26, 2026 that fully vested on July 1, 2026.

Albemarle Corporation director Ralf Hans Cramer reported routine equity compensation and related tax withholding in company stock. On July 1, 2026, he received an annual non-employee director stock award and additional shares from dividends settled in stock under the 2023 Directors Plan. On the same date, a portion of shares from these vesting awards and dividend equivalents was withheld at $136.08 per share to cover associated tax liabilities, rather than sold in the open market. The transactions reflect compensation and tax mechanics, not discretionary buying or selling of Albemarle shares.

ALBEMARLE CORP director Laurie Brlas reported equity awards of common stock as part of non-employee director compensation. On July 1, 2026, Brlas received two acquisitions of common stock valued at $0.00 per share, reflecting stock-based compensation rather than open-market purchases.

The filing shows an award of 1,250 shares of common stock as an annual installment of non-employee director stock compensation under the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation, scheduled to vest on July 1, 2027. It also shows 36 shares issued for dividends accrued on a prior award granted on July 1, 2025 that vested in full on July 1, 2026, which the company elected to settle in stock under the same plan.

After these awards, Brlas holds 7,289 shares of Albemarle common stock directly and 6,900 shares indirectly through a spouse, according to the filing.

ALBEMARLE CORP director Alejandro Daniel Wolff acquired additional equity-based compensation and dividend-related holdings in the company. He received 33 shares of common stock at no cost through an automatic dividend reinvestment program and now directly holds 13,044 common shares.

He also was granted 1,250 Phantom Stock units, which convert 1-for-1 into common stock and are payable as shares under the 2023 Directors Plan, bringing his Phantom Stock balance to 7,590 units. These Phantom Stock amounts include dividend equivalent rights and represent an annual non-employee director stock installment scheduled to vest on July 1, 2027.

Albemarle Corporation director Mark R. Widmar received an equity-based compensation award. He was granted 1,250 Phantom Stock units that convert one-for-one into Albemarle common stock. Following this grant, he holds 1,576 Phantom Stock units in his deferred stock account.

The units are an annual non-employee director stock compensation award under Albemarle’s 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors and are payable in shares of common stock upon distribution events selected under the plan. The award is scheduled to vest on July 1, 2027 and has no expiration date.

Albemarle Corporation director Gerald A. Steiner reported stock-based compensation awards rather than open-market trades. He acquired 36 shares of common stock as an annual non-employee director stock compensation installment under the 2023 Directors Plan, scheduled to vest on July 1, 2027. He also received 1,250 additional shares that represent dividends accrued on a prior stock award granted on July 1, 2025 and vested on July 1, 2026, which the company elected to settle in shares. These transactions reflect equity compensation grants and dividend equivalents, not cash purchases or sales.

ALBEMARLE CORP reported a routine equity compensation award for non-employee director Holly Van Deursen. She received 1,250 Phantom Stock units, which convert 1-for-1 into common stock. These units represent annual director stock compensation under Albemarle’s 2023 Directors Plan and are scheduled to vest on July 1, 2027.

The Phantom Stock will be paid in shares of common stock upon events she has established under the plan. Following this award, Van Deursen now holds 10,028 Phantom Stock units in her deferred stock account. This is a grant/award acquisition, not an open-market purchase or sale.

ALBEMARLE CORP director Diarmuid B. O’Connell reported stock-based compensation awards rather than open-market trades. On July 1, 2026, he acquired a total of 1,286 shares of common stock at no cash cost, recorded as grants or awards.

Footnotes explain that 36 shares are an annual installment of non-employee director stock compensation under the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors, scheduled to vest on July 1, 2027. Additional shares represent dividends accrued on a prior award granted on July 1, 2025 that vested on July 1, 2026, which the company settled in stock issued under the same plan.

The filing also notes that the director’s holdings were adjusted to reflect a transfer of 893 shares of common stock pursuant to an agreement of separation of assets, indicating a reallocation of previously held shares rather than a market sale.

Albemarle Corporation Chairman & CEO J. Kent Masters sold a total of 16,393 shares of Common Stock in open-market transactions on May 15, 2026. The sales were executed in three tranches: 700 shares at a weighted average price of $184.52, 11,867 shares at $183.87, and 3,826 shares at $183.12. Footnotes state the trades were carried out in multiple transactions within price ranges between $182.415 and $184.54 for diversification and tax planning purposes. The disclosure also notes that the reporting person retains significant Albemarle holdings in excess of required stock ownership guidelines.

ALBEMARLE CORP director Alejandro Daniel Wolff increased his holdings through an automatic dividend reinvestment. On April 1, 2026, he acquired 25 shares of common stock as dividends were reinvested under a company program, bringing his direct ownership to 13,011 shares. This was a routine, compensation-related acquisition rather than an open-market purchase.

Albemarle Corporation Chairman & CEO J. Kent Masters reported both stock sales and a gift of shares. On March 10, 2026, he sold a total of 11,783 shares of Albemarle common stock in open-market transactions at weighted-average prices with ranges from $169.63 to $171.89 per share for diversification and tax planning purposes. After these sales, he directly held 134,628 shares.

On March 12, 2026, he made a bona fide gift of 30,716 shares, transferring them to an irrevocable trust over which he has no influence or control. Following this transfer, he directly holds 103,912 shares, which the disclosure notes remain in excess of his required holdings under Albemarle’s stock ownership guidelines.

ALBEMARLE CORP director Alejandro Daniel Wolff increased his stake through automatic dividend reinvestment. On January 2, 2026, he acquired 32 shares of common stock at a stated price of $0.00 per share, bringing his directly held position to 12,986 shares.

The Form 4 also reports earlier dividend reinvestment acquisitions of 46 shares on October 1, 2024, 42 shares on July 1, 2024, 32 shares on April 2, 2024, 29 shares on January 3, 2024, and 25 shares on October 3, 2023. All transactions are described as dividends acquired under an automatic dividend reinvestment program, indicating routine, compensation-like share accumulations rather than open‑market purchases.

Sheorey Neal Ravi reported acquisition or exercise transactions in this Form 4 filing.

Albemarle Corporation’s Chief Financial Officer, Neal Ravi Sheorey, received an equity award of 4,490 shares in the form of restricted stock units at a grant price of $0 per share. These units vest 100% on 03/02/2029, subject to the terms of the applicable award agreement.

The filing also updates his reported holdings to a total of 20,931 shares after the transaction. This amount now includes 4,231 unvested restricted stock units that vest 100% on 02/22/2027, which are being reported as beneficially owned common stock to align reporting methodology among Albemarle insiders.

Norris Eric reported acquisition or exercise transactions in this Form 4 filing.

Albemarle Corporation reported that Chief Commercial Officer Eric Norris received a grant of 4,490 restricted stock units on March 2, 2026. The award has no purchase price and will vest 100% on March 2, 2029, subject to the terms of the award agreement. Following this grant, Norris beneficially owns 53,443 shares of Albemarle common stock directly.

LaBauve Donald J. Jr. reported acquisition or exercise transactions in this Form 4 filing.

Albemarle Corporation executive Donald J. LaBauve Jr., VP, Corporate Controller & CAO, received an award of 698 shares of Common Stock on a grant/award basis at $0.00 per share. Following this award, his directly held Common Stock totaled 10,402 shares.

A related footnote explains that these are restricted stock units that vest 100% on March 2, 2029, subject to the award agreement. He also reported 12,755 shares of Common Stock held indirectly through the Albemarle Corporation Retirement Savings Plan.

Krupa Ander C. reported acquisition or exercise transactions in this Form 4 filing.

Albemarle Corp reported that its General Counsel & Secretary, Ander C. Krupa, was granted 1,796 restricted stock units on March 2, 2026. According to the award terms, these restricted stock units vest 100% on March 2, 2029, increasing the officer’s directly held common stock-related interest to 13,184 shares after the award.

Mummert Mark Richard reported acquisition or exercise transactions in this Form 4 filing.

Albemarle Corp’s Chief Supply Chain Officer, Mark Richard Mummert, received an equity award of 3,143 shares of common stock on 03/02/2026. The award is in the form of Restricted Stock Units that vest 100% on 03/02/2029, subject to the terms of the award agreement. Following this grant, his directly owned common stock holdings total 17,515 shares.

Albemarle Corporation’s Chairman and CEO J Kent Masters reported an equity award. He acquired 22,450 shares in the form of restricted stock units granted at no cash cost, which vest 100% on 03/30/2027. Following this grant, he beneficially owns 146,411 common shares directly.

Anderson Melissa H. reported acquisition or exercise transactions in this Form 4 filing.

Albemarle Corporation executive Melissa H. Anderson, Chief Business Transformation Officer, received a grant of 4,490 shares of common stock on March 2, 2026, at no cost as a stock award. These restricted stock units vest 100% on June 30, 2027, under the award agreement. Following the grant, she directly holds 14,002 shares of common stock and indirectly holds 179.1617 shares through the Albemarle Savings Plan.

Gagarinas Autumn M. reported acquisition or exercise transactions in this Form 4 filing.

Albemarle Corp’s Chief People Officer, Autumn M. Gagarinas, reported an equity award on a Form 4. She received 1,796 shares of common stock in the form of Restricted Stock Units at a stated price of $0.00 per share, bringing her direct holdings to 5,393 shares. The RSUs vest 100% on 03/02/2029, subject to the terms of the award agreement.

Albemarle Corporation reported that senior vice president Cynthia Renee Lima received an equity award of 1,796 shares of common stock as a grant or other acquisition. The award was priced at $0.00 per share, increasing her directly held stake to 14,438 shares. According to the terms, these restricted stock units vest 100% on March 2, 2029, tying a portion of her compensation to the company’s long-term performance.

Albemarle Corporation’s Chief Commercial Officer Eric Norris reported equity compensation activity involving company common stock. He acquired 1,806 shares on February 26, 2026 at $184.93 per share through the vesting of previously granted Performance Stock Units, bringing his direct holdings to 49,738 shares.

On the same date, 785 shares at $184.93 per share were disposed of to cover tax liabilities tied to the 2023 Performance Stock Unit grant vesting. After this tax-withholding disposition, Norris held 48,953 shares of Albemarle common stock directly.

Albemarle Corp executive Mark Richard Mummert reported equity award activity involving company common stock. On February 26, 2026, he acquired 366 shares at $184.93 per share through a grant/award tied to Performance Stock Units originally granted on February 24, 2023. The footnotes explain that these units were split between ROIC and rTSR Performance Stock Units and that all shares earned vested on February 26, 2026. On the same date, 159 shares at $184.93 per share were disposed of to cover tax liabilities associated with this vesting. Following these transactions, he held 14,372 shares of Albemarle common stock directly.

Albemarle Corp executive Melissa H. Anderson reported equity compensation activity involving the company’s common stock. On February 26, 2026, she acquired 1,129 shares through the vesting of Performance Stock Units that were originally granted on February 24, 2023, split between ROIC and rTSR performance awards.

On the same date, 491 shares were disposed of to cover tax liabilities related to this vesting, as a tax-withholding disposition rather than an open‑market sale. After these transactions, she directly owned 9,512 shares of Albemarle common stock and also indirectly held 179.1617 shares through the Albemarle Savings Plan as of this Form 4.

Albemarle Corporation senior vice president Cynthia Renee Lima reported equity compensation activity involving company common stock. On 02/26/2026, she acquired 147 shares at $184.93 per share through the vesting of Performance Stock Units that were originally granted on 02/24/2023.

According to the disclosure, 50% of those Performance Stock Units were based on ROIC performance and 50% on relative total shareholder return, and all shares earned vested on 02/26/2026. On the same date, 64 shares at $184.93 per share were disposed of to cover tax liabilities associated with the vesting, leaving her with 12,642 directly owned shares after these transactions.

Albemarle Corp General Counsel & Secretary Ander C. Krupa reported equity compensation activity involving common stock. On 2/26/2026, she acquired 173 shares at $184.93 per share through a grant or award tied to Performance Stock Units granted on 2/24/2023. On the same date, 80 shares at $184.93 per share were disposed of to satisfy tax liabilities related to the vesting of those units. After these transactions, she directly owned 11,388 common shares.

Albemarle Corp Chief People Officer Autumn M. Gagarinas reported equity compensation activity involving common stock. She acquired 194 shares on February 26, 2026 as a grant tied to Performance Stock Units granted on February 24, 2023, when all earned shares vested. On the same date, 85 shares were disposed of through a tax-withholding transaction to cover liabilities from that vesting. After these transactions, she directly owned 3,597 common shares.

Albemarle Corporation director Mark R. Widmar reported receiving a grant of 325 Phantom Stock units on February 26, 2026. These units convert on a one-for-one basis into Albemarle common stock and are payable as shares upon events established under the company’s 2023 Directors Plan.

The Phantom Stock units have no expiration date. This grant represents a pro‑rata portion of his annual non‑employee director stock compensation under Albemarle’s 2023 Stock Compensation and Deferral Election Plan for Non‑Employee Directors, and the shares are scheduled to vest on July 1, 2026.

Albemarle Corporation executive Donald J. LaBauve Jr., VP, Corporate Controller & CAO, reported stock-based compensation activity in common stock. He received grants or vesting-related acquisitions of 1,266 shares on February 27, 2026 and 219 shares on February 26, 2026.

The filing also shows 361 shares and 67 shares were disposed of on those dates solely to cover tax liabilities tied to restricted stock unit vesting. In addition, 12,755 shares are held indirectly in the Albemarle Savings Plan as of the Form 4 date.

ALBEMARLE CORP Chairman & CEO J Kent Masters reported equity compensation activity involving company common stock. He acquired 9,032 shares at $184.93 per share as a grant or award, bringing his direct holdings to 127,885 shares immediately after this acquisition and 123,961 shares after related tax withholding.

The shares came from Performance Stock Units granted on 02/24/2023, with 50% tied to ROIC performance and 50% to relative total shareholder return (rTSR). No shares were earned under the ROIC component, while all shares under the rTSR component vested on 02/26/2026.

To cover tax liabilities from this vesting, 3,924 shares were disposed of through share withholding at $184.93 per share, which is a tax-withholding disposition rather than an open-market sale.

Collins Michelle T reported acquisition or exercise transactions in this Form 4 filing.

Albemarle Corporation director Michelle T. Collins received a grant of 325 shares of common stock as part of non-employee director stock compensation. The award was granted under the Albemarle Corporation 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors and carries a grant price of $0.00 per share.

These shares are scheduled to vest on July 1, 2026. After this grant, Collins directly holds 325 shares of Albemarle common stock, reflecting her current equity-based compensation as a newly appointed director within the compensation year.

Albemarle Corporation reported that General Counsel & Secretary Ander C. Krupa had 188 shares of common stock withheld on February 24, 2026 at $186.83 per share to cover taxes on vested restricted stock units. After this tax-withholding disposition, Krupa directly owns 11,295 shares.

Albemarle Corp Chief People Officer Autumn M. Gagarinas reported automatic share disposals tied to tax withholding. On 2/24/2026, a total of 566 shares of common stock were withheld at $186.83 per share to cover tax liabilities from vesting restricted stock units granted on 2/24/2023. Following these tax-withholding dispositions, she directly held 3,488 shares of Albemarle common stock.

Albemarle Corporation senior vice president Cynthia Renee Lima reported automatic share disposals to cover taxes on restricted stock unit vesting. On the common stock, 196 shares and 144 shares were withheld on February 24, 2026 at a price of $186.83 per share as tax-withholding dispositions.

After these entries, she directly owned 12,559 common shares. A footnote explains that this filing also updates her reported holdings to include 4,806 unvested RSUs from awards granted on February 24, 2023, aligning treatment of time-based RSUs with other Albemarle reporting persons.

Albemarle Corp executive Melissa H. Anderson reported a tax-related share disposition. On 24 February 2026, 565 shares of common stock were withheld at $186.83 per share to cover tax liabilities tied to vesting restricted stock units granted on 24 February 2023. After this withholding, she directly held 8,874 shares. She also indirectly held 179.1617 shares through the Albemarle Corporation Retirement Savings Plan as of this Form 4.

Albemarle Corporation VP and CAO Donald J. LaBauve Jr. reported a tax-withholding disposition of 164 shares of Common Stock at $186.83 per share on Restricted Stock Units that vested from a grant dated 2/24/2023. After this, he directly holds 8,647 shares, and indirectly holds 12,755 shares through the Albemarle Savings Plan.

ALBEMARLE CORP Chief Commercial Officer Eric Norris reported a tax-related share disposition. On 2/24/2026, 887 shares of common stock were withheld at $186.83 per share to cover tax liabilities from vesting Restricted Stock Units granted on 2/24/2023. After this transaction, Norris directly holds 47,932 shares of Albemarle common stock.

Albemarle Corp Chief Supply Chain Officer Mark Richard Mummert reported a tax-related share disposition tied to restricted stock vesting. On 2/24/2026, 375 shares of common stock were withheld at $186.83 per share to cover tax liabilities, leaving him with 14,165 directly held shares.

Albemarle Corporation’s Chief Commercial Officer Eric Norris reported an open-market sale of company stock. On February 20, 2026, he sold 5,692 shares of Albemarle common stock at a price of $165.45 per share. After this transaction, he directly holds 48,819 shares of Albemarle common stock.

Albemarle Corporation director Gerald A. Steiner reported conversions of deferred phantom stock into common shares. On February 18, 2026, he exercised phantom stock units in two transactions, settling 153 units and 781 units into the same number of Albemarle common shares at a stated price of $0.00 per share.

The phantom stock represents deferred director compensation under Albemarle’s non‑employee director stock compensation and deferral plans, with units converting on a 1‑for‑1 basis into common stock and including dividend equivalent rights. Following these transactions, Steiner’s directly held common and phantom stock balances increased as part of his compensation arrangements rather than open‑market purchases.

Albemarle Corporation’s Chief Business Transformation Officer, Melissa H. Anderson, reported an open‑market sale of Common Stock. On February 13, 2026, she sold 8,454 shares at a weighted average price of $163.71 per share, with individual trade prices ranging from $163.55 to $163.885.

After this sale, Anderson directly held 9,439 shares of Albemarle Common Stock. She also had 179.1617 shares held indirectly under the Albemarle Corporation Retirement Savings Plan, reflecting her plan balance as of the Form 4 date.

Albemarle Corporation's Chairman & CEO and Director reported share withholding transactions related to restricted stock units. On 12/31/2025, three entries of common stock with transaction code "F" show shares withheld to cover tax obligations upon vesting of previously granted RSUs. The amounts withheld were 4,379 shares at $141.44, reducing beneficial ownership to 141,933 shares, then 9,245 shares at $141.44, reducing beneficial ownership to 132,688 shares, and finally 13,835 shares at $141.44, leaving 118,853 shares held directly. The notes explain these relate to RSUs granted on 02/24/2023, 02/22/2024, and 02/27/2025.

Albemarle Corporation (ALB) reported insider equity activity by its Chief Financial Officer. On 11/06/2025, 1,953 Restricted Stock Units (RSUs) converted to common stock (code M) at $0. To cover taxes from the vesting, 854 shares were withheld at $91.26 (code F). After these transactions, the officer directly owned 12,210 common shares.

The filing notes that each RSU converts into one share, and 1,953 RSUs remain outstanding and will vest 100% on 11/06/2026, subject to the award terms.